Peptide articles and guides

Easy-to-read articles on peptide research, dosing, mixing, and the science behind it all.

Showing 1 of 1 articles

B7-33

B7-33 Overview

## What is B7-33? B7-33 is a novel, synthetic compound that was first discovered and developed by a team of researchers at the Monash University in Australia. The development of B7-33 was based on the discovery of the relaxin receptor 1 (RXFP1) and the recognition of its potential as a therapeutic target for a wide range of diseases and conditions. The research team, led by Professor David Handelsman, first synthesized B7-33 in the early 2010s as part of their efforts to develop a functi

B7-33
40 min read Read More